Can I read Beta-Blockers in HFmrEF and HFpEF Patients on EtoBox?

Beta-Blockers in HFmrEF and HFpEF Patients by Karol Andrea is a document available to read on EtoBox.

What is Beta-Blockers in HFmrEF and HFpEF Patients about?

The DELIVER trial examined the use and implications of beta-blockers in patients with heart failure with mildly reduced ejection fraction (HFmrEF) or preserved ejection fraction (HFpEF). The study found that 83% of participants were treated with beta-blockers, which were associated with a lower risk of cardiovascular death or worsening heart failure, without increasing adverse events. Dapagliflozin effectively reduced clinical events regardless of beta-blocker use, highlighting the need for further investig

Author

Karol Andrea

Language

EN